These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23685076)

  • 21. Prostaglandins and leukotrienes: advances in eicosanoid biology.
    Funk CD
    Science; 2001 Nov; 294(5548):1871-5. PubMed ID: 11729303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts.
    Petruzzelli M; Vacca M; Moschetta A; Cinzia Sasso R; Palasciano G; van Erpecum KJ; Portincasa P
    Clin Biochem; 2007 May; 40(8):503-10. PubMed ID: 17321514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis.
    Müller-Decker K; Fürstenberger G
    Mol Carcinog; 2007 Aug; 46(8):705-10. PubMed ID: 17546626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-1 signaling is required for vascular tube formation during development.
    Cha YI; Kim SH; Solnica-Krezel L; Dubois RN
    Dev Biol; 2005 Jun; 282(1):274-83. PubMed ID: 15936346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory effect of retinoic acid on prostaglandin synthesis in cultured cortical astrocytes.
    Kampmann E; Johann S; van Neerven S; Beyer C; Mey J
    J Neurochem; 2008 Jul; 106(1):320-32. PubMed ID: 18394023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandins and the regulation of tumor growth.
    Bishop-Bailey D; Calatayud S; Warner TD; Hla T; Mitchell JA
    J Environ Pathol Toxicol Oncol; 2002; 21(2):93-101. PubMed ID: 12086407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of prostaglandin synthesis inhibition in the renal syndromes associated with non-narcotic analgesics.
    Patrono C
    Med Toxicol; 1986; 1 Suppl 1():23-33. PubMed ID: 3102892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerosis: a redox-sensitive lipid imbalance suppressible by cyclopentenone prostaglandins.
    Gutierrez LL; Maslinkiewicz A; Curi R; de Bittencourt PI
    Biochem Pharmacol; 2008 Jun; 75(12):2245-62. PubMed ID: 18440492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COX-1 and COX-2 in health and disease.
    Adelizzi RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COX inhibitors and their effects on bone healing.
    Gerstenfeld LC; Einhorn TA
    Expert Opin Drug Saf; 2004 Mar; 3(2):131-6. PubMed ID: 15006719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandins, their inhibitors and cancer.
    Lupulescu A
    Prostaglandins Leukot Essent Fatty Acids; 1996 Feb; 54(2):83-94. PubMed ID: 8848435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of prostaglandin activity, part 1: prostaglandin inhibition in the management of nonrheumatologic diseases: immunologic and hematologic aspects.
    Al-Waili NS; Saloom KY; Al-Waili T; Al-Waili A; Al-Waili H
    Adv Ther; 2007; 24(1):189-222. PubMed ID: 17526477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy.
    Wang Q; Morris RJ; Bode AM; Zhang T
    Cancer Res; 2022 Mar; 82(6):949-965. PubMed ID: 34949672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin transport.
    Schuster VL
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():633-47. PubMed ID: 12432949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin signaling in ciliogenesis and development.
    Jin D; Zhong TP
    J Cell Physiol; 2022 Jun; 237(6):2632-2643. PubMed ID: 34927727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in prostaglandin metabolism during growth of the diatom Thalassiosira rotula.
    Di Dato V; Barbarinaldi R; Amato A; Di Costanzo F; Fontanarosa C; Perna A; Amoresano A; Esposito F; Cutignano A; Ianora A; Romano G
    Sci Rep; 2020 Mar; 10(1):5374. PubMed ID: 32214130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro-inflammatory prostaglandins and progression of colorectal cancer.
    Wang D; DuBois RN
    Cancer Lett; 2008 Aug; 267(2):197-203. PubMed ID: 18406516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiological relevance of prostaglandins in oral diseases.
    Yang CY
    Zhonghua Ya Yi Xue Hui Za Zhi; 1989 Jun; 8(2):44-57. PubMed ID: 2701289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear prostaglandin signaling system: biogenesis and actions via heptahelical receptors.
    Gobeil F; Vazquez-Tello A; Marrache AM; Bhattacharya M; Checchin D; Bkaily G; Lachapelle P; Ribeiro-Da-Silva A; Chemtob S
    Can J Physiol Pharmacol; 2003 Feb; 81(2):196-204. PubMed ID: 12710534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer.
    Krishnan AV; Srinivas S; Feldman D
    Dermatoendocrinol; 2009 Jan; 1(1):7-11. PubMed ID: 20046582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.